Omnicell, Inc. — Company profile
Healthcare · Health Information Services · United States
Last price 36.65 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.67B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Details
| Name | Omnicell, Inc. |
| Sector | Healthcare |
| Industry | Health Information Services |
| Employees | 3485 |
| Founded | 1992 |
| Ipo Date | 2001-08-07 |
| Ceo | Randall Lipps |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US68213N1090 |
| Cusip | 68213N109 |
| Cik | 0000926326 |
| Sic | 3571 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Randall A. Lipps | Founder, Executive Chairman and Chief Executive Officer |
| Nnamdi N. Njoku | President and Chief Operating Officer |
| H. Baird Radford III | Executive Vice President and Chief Financial Officer |
| Corey J. Manley J.D. | Executive Vice President, Chief Legal and Administrative Officer and Corporate Secretary |
| Brian H. Nutt | Vice President, Chief Accounting Officer and Corporate Controller |
| Dr. Perry A. Genova Ph.D. | Senior Vice President and Chief Technology Officer |
| David Unger | Vice President of Investor Relations |
| Tomer Stavitsky | Senior Vice President and Chief Corporate Development Officer |
| Stella Prefach | Senior Vice President and Chief Marketing Officer |
| Dave Ford | SVice President and Chief People Officer |
Contact
| Address | 4220 North Freeway, Fort Worth, Texas 76137, United States |
| Phone | 877 415 9990 |
| Website | https://www.omnicell.com |